Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Mahmood

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|February 28, 2002
Comparison of different reduced sampling approaches for the estimation of pharmacokinetic parameters for long half-life drugs in patients with renal or hepatic impairmentI Mahmood
The Journal of Pharmacy and Pharmacology|June 27, 1998
Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestionsI Mahmood
Journal of Pharmaceutical Sciences|April 21, 1998
Integration of in vitro data and brain weight in allometric scaling to predict clearance in humans: some suggestionsI Mahmood
Life Sciences|January 7, 1999
Interspecies scaling of renally secreted drugsI Mahmood
Therapeutic Drug Monitoring|December 16, 1998
Is 10 milligrams selegiline essential as an adjunct therapy for the symptomatic treatment of Parkinson's disease?I Mahmood
International Journal of Clinical Pharmacology and Therapeutics|November 3, 1998
Assessment of metabolites in bioequivalence studies: should bioequivalence criteria be applied on the sum of parent compound and metabolite?I Mahmood
International Journal of Clinical Pharmacology and Therapeutics|December 4, 2003
Center specificity in the limited sampling model (LSM): can the LSM developed from healthy subjects be extended to disease states?I Mahmood
Journal of Clinical Pharmacology|January 6, 2001
Application of preclinical data to initiate the modified continual reassessment method for maximum tolerated dose-finding trialsI Mahmood
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2013
Designing first-in-human dose of coagulation factors: application of pharmacokinetic allometric scalingI Mahmood
Clinical Pharmacokinetics|May 13, 1999
Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drugI Mahmood, C Sahajwalla
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
International Journal of Clinical Pharmacology and Therapeutics|February 28, 2002
Comparison of different reduced sampling approaches for the estimation of pharmacokinetic parameters for long half-life drugs in patients with renal or hepatic impairmentI Mahmood
The Journal of Pharmacy and Pharmacology|June 27, 1998
Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestionsI Mahmood
Journal of Pharmaceutical Sciences|April 21, 1998
Integration of in vitro data and brain weight in allometric scaling to predict clearance in humans: some suggestionsI Mahmood
Life Sciences|January 7, 1999
Interspecies scaling of renally secreted drugsI Mahmood
Therapeutic Drug Monitoring|December 16, 1998
Is 10 milligrams selegiline essential as an adjunct therapy for the symptomatic treatment of Parkinson's disease?I Mahmood
International Journal of Clinical Pharmacology and Therapeutics|November 3, 1998
Assessment of metabolites in bioequivalence studies: should bioequivalence criteria be applied on the sum of parent compound and metabolite?I Mahmood
International Journal of Clinical Pharmacology and Therapeutics|December 4, 2003
Center specificity in the limited sampling model (LSM): can the LSM developed from healthy subjects be extended to disease states?I Mahmood
Journal of Clinical Pharmacology|January 6, 2001
Application of preclinical data to initiate the modified continual reassessment method for maximum tolerated dose-finding trialsI Mahmood
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 17, 2013
Designing first-in-human dose of coagulation factors: application of pharmacokinetic allometric scalingI Mahmood
Clinical Pharmacokinetics|May 13, 1999
Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drugI Mahmood, C Sahajwalla
Pageof 10